Glenmark gets FDA green light for generic Westcort cream

Press enter to search
Close search
Open Menu

Glenmark gets FDA green light for generic Westcort cream

By Sandra Levy - 10/15/2018
Glenmark Pharmaceuticals has received the Food and Drug Administration’s blessing for hydrocortisone valerate cream, 0.2%.

The product, which is used for providing relief in inflammation and itching due to various skin conditions, is the generic version of Sun Pharmaceuticals’ Westcort Cream, 0.2%.

Westcort Cream had a market value of approximately $17 million for the 12-month period ending August 2018, according to IQVIA data.

RELATED TOPICS